Tag: Spirosure
CAIRE acquires respiratory device maker
June 5, 2020HME News Staff
BALL GROUND, Ga. - CAIRE has acquired Spirosure, a California-based company that recently launched its first product to market, the Fenom Pro, a device that measures FeNO, a key indicator of allergic inflammation in asthmatic patients. “FeNo is quickly becoming recognized by the clinical community as an important diagnostic and management tool for clinicians who treat asthma patients,” said Earl Lawson, CAIRE president and CEO. “The acquisition of Spirosure further diversifies our...
Sponsored Stories
How Advanced Diabetes Supply is Driving Value-Based Health Outcomes
By Advanced Diabetes SupplySOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office SupportCyber Siege: The Financial Vulnerability Healthcare Didn't See Coming
By Strategic Office SupportA new staffing model that delivers ready-to-work pros, boosting efficiency and lowering costs.
By Tactical Back Office